CareDx beats Q3 2026 estimates with non-GAAP EPS $0.70 (+2233% YoY), revenue $139.4M (+39% YoY), raises 2026 revenue and adjusted EBITDA guidance
- Raised full-year 2026 revenue guidance to $520–$530 million and adjusted EBITDA guidance to $90–$100 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.